Prelude Capital Management, LLC Sc Pharmaceuticals Inc. Transaction History

Prelude Capital Management, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 16, 2021	SELL	$5.17 - $9.41 $2,068 - $3,764	-400 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$7.12 - $8.86 $2,848 - $3,544	400 New	400 $3,000
Q4 2019 Feb 14, 2020	SELL	$4.1 - $6.21 $5,329 - $8,073	-1,300 Closed	0 $0
Q3 2019 Nov 14, 2019	BUY	$3.24 - $7.35 $4,212 - $9,555	1,300 New	1,300 $8,000
Q2 2018 Aug 14, 2018	SELL	$5.53 - $15.4 $134,544 - $374,682	-24,330 Closed	0 $0
Q1 2018 May 15, 2018	BUY	$11.62 - $17.32 $282,714 - $421,395	24,330 New	24,330 $302,000

27.7M

39.2K

2.6K

Ticker SCPH
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 27,402,100
Market Cap $150M
Description
scPharmaceuticals Inc., a pharmaceutical company, engages in the development and commercialization of various pharmaceutical products. The company's lead product candidate is FUROSCIX that consists of formulation of furosemide, which is delivered through an on-body infusor for treatment of congestion in patients with heart failure. Its product p...

Get notified when there are updates to the investment portfolio of Prelude Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Prelude Capital Management, LLC with notifications on news.